









Markets
/
Stocks
/
nasdaq-prva
/

Privia Health Group Inc

PRVA

22.605USD

+0.395+1.78%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

2.77BMarket Cap

186.85P/E TTM



Privia Health Group Inc

22.605

+0.395+1.78%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-17

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

1 / 72

Overall Ranking

57 / 4723

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 21 analysts

Buy

Current Rating

30.579

Target Price

+37.00%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improve patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The platform supports multiple provider types, enables scalable operations, and delivers patient centric in-person and virtual access to care, quality metrics, and lower cost of care. It provides management services to each Medical Group though a local management services organization.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 27.99% year-on-year.

Overvalued

The company’s latest PE is 180.38, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 129.73M shares, decreasing 5.79% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 11.47M shares of this stock.

Financial Health

Currency: USD Updated：2025-09-17

The company's current financial score is 8.82, which is higher than the Healthcare Providers & Services industry's average of 7.42. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 521.15M, representing a year-over-year increase of 23.40%, while its net profit experienced a year-over-year increase of 22.50%.

Score

Industry at a Glance

Previous score

8.82

Change



Financials

9.15

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

9.47

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.44

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

9.52

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.53

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-17

The company’s current valuation score is 5.11, which is higher than the Healthcare Providers & Services industry's average of 2.35. Its current P/E ratio is 180.38, which is -5.14% below the recent high of 171.11 and 53.37% above the recent low of 84.10.

Score

Industry at a Glance

Previous score

5.10

Change

0.01

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 1/72

No Data

Earnings Forecast

Currency: USD Updated：2025-09-17

The company’s current earnings forecast score is 8.48, which is higher than the Healthcare Providers & Services industry's average of 7.58. The average price target for Privia Health Group Inc is 30.00, with a high of 37.00 and a low of 21.00.

Score

Industry at a Glance

Previous score

8.48

Change

Support & Resistance

No Data

Analyst Rating

Based on 21 analysts

Buy

Current Rating

30.579

Target Price

+37.68%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Privia Health Group Inc

PRVA

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Natera Inc

NTRA

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-17

The company’s current price momentum score is 6.86, which is lower than the Healthcare Providers & Services industry's average of 6.88. Sideways: Currently, the stock price is trading between the resistance level at 23.81 and the support level at 20.70, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.99

Change

-0.13

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.249

Neutral

RSI(14)

55.856

Neutral

STOCH(KDJ)(9,3,3)

22.580

Neutral

ATR(14)

0.626

Low Volatility

CCI(14)

-87.913

Neutral

Williams %R

68.883

Sell

TRIX(12,20)

0.378

Sell

StochRSI(14)

61.813

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

22.453

Buy

MA10

22.815

Sell

MA20

22.517

Buy

MA50

21.159

Buy

MA100

22.093

Buy

MA200

22.381

Buy

Institutional Confidence

Currency: USD Updated：2025-09-17

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 8.03. The latest institutional shareholding proportion is 106.38%, representing a quarter-over-quarter decrease of 5.17%. The largest institutional shareholder is The Vanguard, holding a total of 11.47M shares, representing 9.35% of shares outstanding, with 1.63% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

15.42M

-2.13%

Fidelity Management & Research Company LLC

15.62M

-1.01%

Durable Capital Partners LP

11.49M

The Vanguard Group, Inc.

Star Investors

11.25M

-1.31%

Boehler (Adam)

5.77M

+8.56%

Rubicon Founders, LLC

5.77M

Riverbridge Partners, LLC

5.52M

-5.27%

State Street Global Advisors (US)

4.11M

-3.15%

Van Berkom & Associates Inc.

2.01M

Principal Global Investors (Equity)

2.96M

-3.97%

Risk Assessment

Currency: USD Updated：2025-09-17

The company’s current risk assessment score is 5.52, which is higher than the Healthcare Providers & Services industry's average of 4.17. The company's beta value is 0.82. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.